Glioblastoma (GBM) in elderly patients: A randomized phase III trial comparing survival in patients treated with 6-week radiotherapy (RT) versus hypofractionated RT over 2 weeks versus temozolomide single-agent chemotherapy (TMZ). - Malmstrom,A.; Grønberg,B.H.; Stupp,R. (J Clin Oncol, 2010)